News · 26 weeks50-91%
2025-12-142026-06-07
Mix3490d
- Insider16(47%)
- SEC Filings8(24%)
- Leadership3(9%)
- Other3(9%)
- Earnings2(6%)
- Analyst2(6%)
Latest news
25 items- ANALYSTAcadia Healthcare upgraded by Jefferies with a new price targetJefferies upgraded Acadia Healthcare from Hold to Buy and set a new price target of $30.00
- SECSEC Form 8-K filed by Acadia Healthcare Company Inc.8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
- SECSEC Form S-8 filed by Acadia Healthcare Company Inc.S-8 - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- INSIDERNew insider Duckworth David M. claimed ownership of 750 shares (SEC Form 3)3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)
- INSIDERDirector Fucci Michael was granted 6,331 shares, increasing direct ownership by 29% to 28,152 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Waud Reeve B was granted 15,907 shares, increasing direct ownership by 27% to 75,859 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Bernhard Jason was granted 11,455 shares, increasing direct ownership by 34% to 45,359 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Harris Patrice A was granted 6,331 shares, increasing direct ownership by 55% to 17,914 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Kelly Ralph David was granted 6,331 shares, increasing direct ownership by 32% to 26,358 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Gregg Vicky B was granted 6,331 shares, increasing direct ownership by 17% to 42,628 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Cancelmi Daniel J was granted 6,331 shares, increasing direct ownership by 96% to 12,956 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Grieco William was granted 6,331 shares, increasing direct ownership by 7% to 96,212 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDERDirector Bissell E. Perot was granted 11,831 shares, increasing direct ownership by 26% to 57,486 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- INSIDEREVP, CLAO and Secretary Farley Brian covered exercise/tax liability with 5,063 shares, decreasing direct ownership by 4% to 139,122 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECSEC Form 8-K filed by Acadia Healthcare Company Inc.8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- ANALYSTAcadia Healthcare upgraded by Raymond James with a new price targetRaymond James upgraded Acadia Healthcare from Outperform to Strong Buy and set a new price target of $39.00
- INSIDEREVP, CLAO and Secretary Farley Brian was granted 37,510 shares, increasing direct ownership by 35% to 144,185 units (SEC Form 4)4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- PRAcadia Healthcare Announces First Quarter 2026 ResultsCompany Increases Full Year 2026 Adjusted EBITDA and Adjusted EPS Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per patient day of 5.6% and an increase in patient days of 1.6% Net income attributable to Acadia totaled $0.05 per diluted share, compared with $0.09 per diluted share in the prior-year period Adjusted net income attributable to
- PRNational Veterinary Associates Appoints Todd S. Young as Chief Financial OfficerNational Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. "I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ:AC
- SECAcadia Healthcare Company Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)
- PRAcadia Healthcare Appoints David Duckworth as Interim Chief Financial OfficerReaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int
- INSIDERSEC Form 4 filed by Farley Brian4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)
ACHC FAQ
6 questionsWhat does Acadia Healthcare Company Inc. do?
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and...Where does ACHC stock trade?
Acadia Healthcare Company Inc. (ACHC) is listed on NASDAQ.What sector and industry is ACHC in?
Acadia Healthcare Company Inc. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about ACHC?
Acadia Healthcare Company Inc. has had 8 recent analyst actions on file. The most recent action was from Jefferies: Buy with a $3000.00 price target on 2026-06-03. Recent price targets range from $1300.00 to $3900.00.What companies are similar to ACHC?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), HUM (Humana Inc.). Compare ACHC side-by-side with any of them on Quantisnow.How can I track ACHC on Quantisnow?
Quantisnow aggregates Acadia Healthcare Company Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACHC to receive live email and push alerts on every new disclosure.